Advertisement

Advertisement

HURA Stock Latest News

TuHURA Biosciences initiated with an Outperform at Citizens

The FlyTuHURA Biosciences initiated with an Outperform at Citizens

TuHURA Biosciences Secures $50 Million Credit Facility

PremiumCompany Announcements

TuHURA Biosciences Secures $50 Million Credit Facility

14d ago

TuHURA Biosciences initiated with a Buy at Rodman & Renshaw

PremiumThe Fly

TuHURA Biosciences initiated with a Buy at Rodman & Renshaw

21d ago

TuHURA Biosciences Approves 2025 Executive Compensation Adjustments

PremiumCompany Announcements

TuHURA Biosciences Approves 2025 Executive Compensation Adjustments

28d ago

TuHURA Biosciences files INDA for TBS-2025 in blood-related cancers

PremiumThe Fly

TuHURA Biosciences files INDA for TBS-2025 in blood-related cancers

3M ago

VOO vs. VTI vs. VTWO: Which Vanguard ETF Offers the Best Upside in 2026?

PremiumMarket NewsVOO vs. VTI vs. VTWO: Which Vanguard ETF Offers the Best Upside in 2026?

3M ago

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/6/26

Market News

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/6/26

3M ago

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/4/26

Market News

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/4/26

3M ago

TuHURA Biosciences: Undervalued Orphan-Drug Oncology Pipeline with Multiple Near-Term Catalysts Supports Reiterated Buy and $10 Target

PremiumRatings

TuHURA Biosciences: Undervalued Orphan-Drug Oncology Pipeline with Multiple Near-Term Catalysts Supports Reiterated Buy and $10 Target

3M ago

TuHURA Biosciences says FDA grants Orphan Drug Designation to IFx-2.0

PremiumThe Fly

TuHURA Biosciences says FDA grants Orphan Drug Designation to IFx-2.0

3M ago

TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice

PremiumCompany Announcements

TuHURA Biosciences Receives Nasdaq Minimum Bid Price Notice

3M ago

TuHURA Biosciences price target lowered to $10 from $12 at H.C. Wainwright

PremiumThe Fly

TuHURA Biosciences price target lowered to $10 from $12 at H.C. Wainwright

4M ago

TuHURA Biosciences announces release of Kintara’s CVR

PremiumThe FlyTuHURA Biosciences announces release of Kintara’s CVR

5M ago

TuHURA Biosciences provides updates across portfolio

The Fly

TuHURA Biosciences provides updates across portfolio

5M ago

TuHURA Biosciences Announces Securities Purchase Agreement

Company Announcements

TuHURA Biosciences Announces Securities Purchase Agreement

5M ago

TuHURA Biosciences announces $15.6M registered direct offering

PremiumThe Fly

TuHURA Biosciences announces $15.6M registered direct offering

5M ago

TuHURA Biosciences presents research on potential role of DOR at ASH

PremiumThe Fly

TuHURA Biosciences presents research on potential role of DOR at ASH

5M ago

TuHURA Biosciences Amends Loan Agreement, Secures Full $3M

PremiumCompany Announcements

TuHURA Biosciences Amends Loan Agreement, Secures Full $3M

5M ago

TuHURA Biosciences’ Shelf Registration Statement Effective

PremiumCompany Announcements

TuHURA Biosciences’ Shelf Registration Statement Effective

5M ago

TuHURA Biosciences Completes Acquisition of Kineta, Inc.

PremiumCompany AnnouncementsTuHURA Biosciences Completes Acquisition of Kineta, Inc.

6M ago

TuHURA Biosciences Reports Q3 Financials and Advances Cancer Therapy Trials

Company Announcements

TuHURA Biosciences Reports Q3 Financials and Advances Cancer Therapy Trials

6M ago

TuHURA Biosciences price target lowered to $8 from $15 at Maxim

The Fly

TuHURA Biosciences price target lowered to $8 from $15 at Maxim

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >